Global Virology and Bacteriology Market to be Dominated by North America Region During the Forecast Period
Constantly rising incidence
of infectious diseases to drive the growth of global virology and bacteriology
market
According
to TechSci Research report, “Global
Virology
and Bacteriology Market By Technology (Molecular
Diagnostics, Information Technology, Immunoassays, Diagnostic Imaging,
Chromatography, Monoclonal Antibodies, Others), By Disease (Respiratory System,
Urinary Tract, And Bloodstream Diseases; Gastrointestinal and Periodontal
Diseases; Sexually Transmitted Diseases), By End User (Clinics, Hospitals,
Diagnostic Centers, Laboratories, And Blood Banks), By Company, By Region,
Forecast & Opportunities, 2025”,
Global virology and bacteriology market is expected to witness formidable
growth rate during the forecast period. Continuously growing cases of
infectious diseases worldwide is
one of the major factors accounting for the growth of global
virology and bacteriology market. Moreover, advances in molecular diagnostic
technologies is expected to bode well for the growth of global virology and
bacteriology market through the forecast period. In addition to this, wider
availability of immunosuppressive drugs, is anticipated to positively influence
the growth of global virology and bacteriology market in the years to come.
Also, continuing spread of AIDS coupled with threat of bioterrorism is making
headway for the growth of global virology and bacteriology market across the
globe. Along with this, supportive government funding and increasing
investments by public and private bodies is expected to fuel to the market
growth during the next five years. However, there are some factors that can act
as major impediments to the growth of global virology and bacteriology market
through 2025 such as concerns pertaining to reimbursement policies and
regulatory scenarios.
Browse XX market data Tables and XX Figures
spread through XXX
Pages and an in-depth TOC on" Global Virology
and Bacteriology Market"
https://www.techsciresearch.com/report/virology-and-bacteriology-market/4700.html
Global
virology and bacteriology market can be segmented based on technology, disease,
end user, company, and region. Considering the end user, the market is
fragmented into clinics, hospitals, diagnostic centers, laboratories, and blood
banks. The hospitals segment dominated the global virology and bacteriology
market in terms of largest market share until 2019 and is further anticipated
to maintain its dominance during the forecast period as well. This is because
of presence of advanced healthcare practices and large patient pool. Moreover, increasing
number of clinical trials is further anticipated to drive the growth of segment
over the coming years. In term of disease, the market is segregated into respiratory
system, urinary tract, and bloodstream diseases; gastrointestinal and
periodontal diseases; sexually transmitted diseases. Out of which, respiratory
system, urinary tract, and bloodstream diseases segment accounted for largest
market share until 2019 and is further anticipated to grow at a high pace in
the years to come on account of increase in population suffering from respiratory disorders.
Fujirebio Diagnostics Inc., Cepheid,
Diasorin, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Scienion
AG, Grifols, Qiagen, Eiken Chemical Co Ltd, Sequenom, bioMerieux SA, Siemens
AG, Hologic Inc., Diamedix Inc., Leica Biosystems Nussloch GmbH, F. Hoffmann-La
RocheLtd, Abbot, GSK Biologicals, Roche, Affymetrix, are among others
are the leading players operating in global virology and bacteriology market. The market players are adopting several growth strategies
to enhance virology and bacteriology market. Other competitive strategies
include product launches; mergers & acquisitions; agreements, partnerships,
and collaborations; and expansions to diverse their product portfolio in order
to strengthen their market position.
Download sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=4700
customers can also request for 10% free customization on
this report.
“North America is
forecast to dominate the global virology and bacteriology market though 2025 on
account of rapid adoption of advanced diagnostic and testing methods in the
region. Furthermore, increased spending on healthcare, presence of advanced clinical
laboratories and medical device manufacturing companies and favorable
government policies, is also contributing to the growing trend. Additionally, Asia-Pacific
is forecast to register highest growing CAGR over the years to come, which can
be attributed to expanding research and development facilities in the field of
diagnostics.”, said Mr. Karan Chechi, Research Director with TechSci Research,
a research based global management consulting firm.
“Global Virology and Bacteriology Market By Technology
(Molecular Diagnostics, Information Technology, Immunoassays, Diagnostic
Imaging, Chromatography, Monoclonal Antibodies, Others), By Disease
(Respiratory System, Urinary Tract, And Bloodstream Diseases; Gastrointestinal
and Periodontal Diseases; Sexually Transmitted Diseases), By End User (Clinics,
Hospitals, Diagnostic Centers, Laboratories, And Blood Banks), By Region,
Forecast & Opportunities, 2025” has evaluated the future growth potential of global virology
and bacteriology market and provides statistics & information on market
size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges and opportunities in global virology
and bacteriology market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]